Wird geladen...

Circulating Tumors Cells as Biomarkers: Progress Toward Biomarker Qualification

Personalized cancer medicine requires the development of tumor-specific biomarkers to optimize selection of targeted therapies and to better assess response to therapy. Current efforts in several tumor types have shown that patients in whom circulating tumor cells (CTCs) are detected have an inferio...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Danila, Daniel C., Pantel, Klaus, Fleisher, Martin, Scher, Howard I.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2011
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3985131/
https://ncbi.nlm.nih.gov/pubmed/22157288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e31823e69ac
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!